00:00
529
Dr. James Berenson talks about the 10-year survival data presented at ASH 2011 and covers a large number of drugs that are both nearing an FDA decision and those that are further upstream. For patients interested in the science of how these drugs work, Dr. Berenson shares both his insight and his excitement at this point in time for myeloma treatment.
Loading more stuff…